BCLI - brainstorm-cell.com Uzoq muddatli majburiyatlarning kapitalga nisbati

BrainStorm Cell Therapeutics Inc. (BCLI) tovar belgisi

Brainstorm Cell (BCLI) kompaniyasining kunlik narxlar grafigi, hozirda 0.00 darajasida turibdi, NurOwn platformasining neyronlarni regeneratsiya qilish salohiyatiga asoslangan. Dorining tasdiqlanishi terapiyaning kritik tabiati tufayli kompaniyaga to'liq narx belgilash vakolatini beradi. Biznes samaradorligi biomateriallarning suyuq azotda nuqsonsiz tashilishi bilan bog'liq. Barqaror rivojlanish aksiyalar opsion tizimi orqali saqlab qolingan yuqori malakali olimlar jamoasi tomonidan kafolatlanadi.

BCLI - Brainstorm Cell Therapeutics Inc. Uzoq muddatli qarzning o'z kapitaliga nisbati 04.07.2022 - 02.08.2025 oraligʻida

Brainstorm Cell kompaniyasining tahliliy kesimlari

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kursi Brainstorm Cell Therapeutics Inc.|BCLI - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Brainstorm Cell Therapeutics Inc.|BCLI - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati BrainStorm Cell Therapeutics|BCLI - Kompaniyaning balans qiymati|Balans qiymatiga nisbatan bozor qiymati brainstorm-cell.com|BCLI - Kompaniyaning jami aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning kapitalga nisbati Brainstorm Cell|BCLI - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati brainstorm-cell.com|BCLI - Kompaniya qarzlari|Qarzning sof aktivlarga nisbati Brainstorm Cell Therapeutics Inc.
Kompaniyaning dastlabki tahlili:BCLI, Brainstorm Cell Therapeutics Inc.
brainstorm-cell.com asosiy tovari

Ushbu ko'rsatkich bir yildan ortiq muddatli majburiyatlarning kapitalning bozor qiymatiga nisbati sifatida hisoblanadi. U biznesning tashqi moliyalashtirishga bog'liqlik darajasini va uning moliyaviy barqarorligini belgilaydi. Brainstorm Cell kompaniyasi uchun ushbu qarz tuzilmasi neyrodegenerativ kasalliklar sohasidagi diversifikatsiyalashgan tadqiqotlarni qo'llab-quvvatlaydi. Bu resurslarni turli dasturlar bo'yicha taqsimlash orqali tartibga soluvchi o'zgarishlar risklarini yumshatadi. Uzoq muddatli qarzning kapitalga nisbati dinamikasi kompaniyaning joriy moliyaviy leveraj darajasini aks ettiradi.

Muhim raqobatchilar

Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi Biogen Inc|Neurocrine Biosciences Inc - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Regencell Corp RGC|Uzoq muddatli qarzning o'z kapitaliga nisbati AXSM (Axsome Therapeutics)|acadia-pharm.com - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Xenon (XENE)|VKTX: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati SUPN|Catalyst Corp (CPRX) - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati Denali Therapeutics|Uzoq muddatli qarzning o'z kapitaliga nisbati HRMY|Biohaven (BHVN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti Amylyx Pharmaceuticals Inc (AMLX)|Uzoq muddatli qarzning kapitalga nisbati TRVI (Trevi Pharma)|Uzoq muddatli qarzning kapitalga nisbati Praxis Corp PRAX|Uzoq muddatli qarzning kapitalga nisbati AVXL (Anavex Life Sciences)|CBLL: Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Prothena Corp|ALEC (Alector) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|ANNX: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Omeros Corp. (OMER)|Uzoq muddatli qarzning o'z kapitaliga nisbati Neurogene Inc.|Uzoq muddatli kreditlarning kapitalga nisbati ACIU (acimmune.com)|VYGR: Uzoq muddatli qarzning o'z kapitaliga nisbati|Neumora - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Scilex Holding Co. (SCLX)|TVGN: Uzoq muddatli qarzning kapitalga koeffitsiyenti|ACOG (alphacognition.com) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati cogrx.com|IKT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti Cassava Sciences Inc|Uzoq muddatli qarzning kapitalga nisbati ASRT (Assertio Holdings, Inc.)|Uzoq muddatli qarzning o'z kapitaliga nisbati coyatherapeutics.com (COYA)|VTGN: Uzoq muddatli qarzning kapitalga nisbati|Ovid Therapeutics Inc - Uzoq muddatli majburiyatlarning kapitalga nisbati|ABOS - Uzoq muddatli qarzning o'z kapitaliga nisbati|CRVO: Uzoq muddatli qarzning o'z kapitaliga nisbati|alteritytherapeutics.com (ATHE) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Clene (CLNN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati PepGen Inc|Uzoq muddatli qarzning o'z kapitaliga nisbati jupiterneurosciences.com|Uzoq muddatli qarzning kapitalga nisbati RLMD (Relmada Therapeutics, Inc.)|Uzoq muddatli qarzning o'z kapitaliga nisbati ANVS (Annovis Bio Inc)|Uzoq muddatli qarzning o'z kapitaliga nisbati Grace Therapeutics GRCE|Uzoq muddatli qarzning o'z kapitaliga nisbati Firefly Neuro AIFF|Uzoq muddatli qarzning kapitalga nisbati KLTO (ANEW Medical, Inc.)|NRSN: Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Reviva Pharmaceuticals Holdings, Inc.|MetaVia (MTVA) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati NRXS (NeurAxis, Inc)|Uzoq muddatli majburiyatlarning kapitalga nisbati Helius Medical Technologies Inc. (HSDT)|Uzoq muddatli qarzning o'z kapitaliga nisbati PASG|Uzoq muddatli qarzning kapitalga nisbati NEUP (bionomics.com.au)|Uzoq muddatli qarzning o'z kapitaliga nisbati Minerva Neurosciences, Inc.|Athira Pharma Inc - Uzoq muddatli qarzning kapitalga koeffitsiyenti|ADXN (Addex Therapeutics, Ltd.) - Uzoq muddatli qarzning o'z kapitaliga nisbati|ALZN - Uzoq muddatli majburiyatlarning kapitalga nisbati|cyclerion.com (CYCN) - Uzoq muddatli qarzning kapitalga nisbati|PTIX (Protagenic Therapeutics, Inc.) - Uzoq muddatli qarzning o'z kapitaliga nisbati|KTTA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti Cortigent Medical|Uzoq muddatli qarzning kapitalga nisbati ATXI|Uzoq muddatli qarzning kapitalga nisbati Cara Therapeutics Inc (CARA)|Uzoq muddatli qarzning kapitalga nisbati CHRO|Eliem Therapeutics, Inc. - Uzoq muddatli qarzdorlikning kapitalga nisbati|Intra-Cellular (ITCI) - Uzoq muddatli qarzning o'z kapitaliga nisbati|LBPH: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Marinus - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati NKGen Biotech Corp|NeuroBo Pharmaceuticals (NRBO) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli kreditlarning kapitalga nisbati SAGE|Synaptogenix - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati TRVN (Trevena Inc.)|Uzoq muddatli qarzning o'z kapitaliga nisbati Vigil Neuroscience, Inc.|Anew Medical Inc. - Uzoq muddatli qarzning kapitalga koeffitsiyenti|CERE: Uzoq muddatli qarzning o'z kapitaliga nisbati